# Custos Privatstiftung

> Custos Privatstiftung is a VC fund backing Software, Biopharma and Nutrition. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Feb 2023
- Lead investor: 0%
- Last updated: Aug 2026

Custos Privatstiftung is a private company.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $5M–$18M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 25% |
| Biopharma | 1 | 25% |
| Nutrition | 1 | 25% |
| Biotechnology | 1 | 25% |
| Sustainability | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Seed | 1 | 25% |
| Series C | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 25% |
| Austria | 1 | 25% |
| New Zealand | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Authentic Vision | Authentic Vision is best known for providing new and innovative ways of brand protection. The company holds several patents and is cooperating closely with universities and the world’s leading security printing companies to stay abreast of the latest developments in the fields of brand/value protection and costumer communication solutions. | $6M | Series C | Feb 06, 2023 |  |
| Helico | Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world. | $1.3M | Seed | May 17, 2022 |  |
| Authentic Vision | Authentic Vision is best known for providing new and innovative ways of brand protection. The company holds several patents and is cooperating closely with universities and the world’s leading security printing companies to stay abreast of the latest developments in the fields of brand/value protection and costumer communication solutions. | $5M | Series B | Oct 29, 2020 |  |
| Innovopro | InnovoPro is committed to bringing unique plant-based protein ingredients to the global food market in order to create nutritious, tasty, safe, and sustainable food products. With an excellent nutritional profile, free from properties and wide usability in the food industry, InnovoPro’s chickpea protein is the best choice for the growingplant-based protein market.InnovoPro was founded on 2013 by Dr. Ascher Shmulewitz an experienced inventor and investor, and has made considerable progress in developing chickpea proteins and other chickpea ingredients.InnovoPro has been recognized as an innovator of disruptive technology in the food industry. | $18M | Series B | Apr 23, 2020 |  |

4 of 4 investments shown.

## Co-investors
- [Dolby Family Ventures](https://shizune.co/investors/profile/dolby-family-ventures) — VC Fund, 2 deals together
- [CPT Capital](https://shizune.co/investors/profile/cpt-capital) — VC Fund, 1 deal together
- [Gronova Vision](https://shizune.co/investors/profile/gronova-vision) — VC Fund, 1 deal together
- [Icehouse Ventures](https://shizune.co/investors/profile/icehouse-ventures) — VC Fund, 1 deal together
- [Jerusalem Venture Partners (JVP)](https://shizune.co/investors/profile/jerusalem-venture-partners) — VC Fund, 1 deal together
- [Joint Effects](https://shizune.co/investors/profile/joint-effects) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Icehouse Ventures](https://shizune.co/investors/profile/icehouse-ventures) — VC Fund
- [Enterprise Angels](https://shizune.co/investors/profile/enterprise-angels) — VC Fund
- [K1W1](https://shizune.co/investors/profile/k1w1) — VC Fund

## Featured in investor lists
- [Health Care Investors in New Zealand](https://shizune.co/investors/health-care-investors-new-zealand)
- [Health Care VC Funds in New Zealand](https://shizune.co/investors/health-care-vc-funds-new-zealand)
- [Biotech Investors in New Zealand](https://shizune.co/investors/biotech-investors-new-zealand)
- [Biotech VC Funds in New Zealand](https://shizune.co/investors/biotech-vc-funds-new-zealand)
- [Biotech VC Funds in Oceania](https://shizune.co/investors/biotech-vc-funds-oceania)

## FAQ

### What does Custos Privatstiftung invest in?

Custos Privatstiftung invests primarily in Software, Biopharma and Nutrition startups, most often at Series B and Seed stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Custos Privatstiftung's check size?

Custos Privatstiftung typically joins rounds of $5M–$18M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Custos Privatstiftung participates in.

### When did Custos Privatstiftung last invest?

The most recent investment recorded for Custos Privatstiftung closed in Feb 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co